Hearing health

Demant identifies cochlear implant fault, plans market return in late 2022

Hearing aid giant Demant has got to the bottom of the fault which has caused problems with one of its cochlear implant products, and expects to resume sales in the third quarter of 2022.
Photo: Jens Dresling
Photo: Jens Dresling
by mikkel aabenhus hemmingsen, translated by catherine brett

According to Demant, the problems with its Neuro Zti cochlear implants are close to being resolved.

Already a subscriber?Log in here

Read the whole article

Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

With your free trial you get:

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
    • Must be at least 8 characters, including three of: Uppercase, lowercase, numbers, symbols
    Must contain at least 2 characters
    Must contain at least 2 characters

    Get full access for you and your coworkers

    Start a free company trial today

    Share article

    Related articles

    Sign up for our newsletter

    Stay ahead of development by receiving our newsletter on the latest sector knowledge.

    Newsletter terms

    Front page now

    Further reading

    Jobs